BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 29, 2026
Breaking News: Best of BioWorld Science: Q2
Breaking News: Science fiction realized: BCI tech is here
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
Pharmacokinetic profile of GTS-21 studied in rats after parenteral, oral dosing
May 14, 1998
Myotrophin declared "potentially approvable" by FDA
May 14, 1998
Phase II clinical trial initiated for Neotrofin
May 14, 1998
Phase I clinical trial of novel analgesic to begin in Sweden
May 13, 1998
Phase III trials in progress for HMR antipsychotic agent
May 13, 1998
Pharmacia & Upjohn submits NDA for Edronax
May 12, 1998
Actiq trial results published; NDA amendment filed
May 11, 1998
Rasagiline demonstrates neuroprotective effects on dopaminergic neurons
May 11, 1998
Enzyme inhibitors useful for neurodegenerative disorders prepared at P&U
May 11, 1998
Rebif reduces disease activity in patients with MS
May 8, 1998
Previous
1
2
…
2612
2613
2614
2615
2616
2617
2618
2619
2620
…
2816
2817
Next
RSS